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SUMMARY
Human adipose mesenchymal stem cells are a heterogeneous population, where cell cultures derived from single cell-expanded clones present varying degrees of differential plasticity. This work focuses on the immunomodulatory/antiinflammatory properties of these cells. To this end, 5 single cell clones were isolated (generally called 1.X and 3.X) from 2 volunteers. Regarding the expression level of the lineage-characteristic surface antigens, clones 1.10 and 1.22 expressed the lowest amounts, while clones 3.10 and 3.5 expressed more CD105 than the rest and clone 1.7 expressed higher amounts of CD73 and CD44. Regarding cytokine secretion, all clones were capable of spontaneously releasing high levels of IL-6 and low to moderate levels of IL-8. These differences can be explained in part by the distinct methylation profile exhibited by the clones. Furthermore and after lipopolysaccharide stimulation, clone 3.X produced the highest amounts of proinflammatory cytokines such as IL-1, while clones 1.10 and 1.22 highly expressed IL-4 and IL-5. In co-culture experiments, clones 1.X are altogether more potent inhibitors than clones 3.X for proliferation of total, CD3 + T, CD4 + T and CD8 + T lymphocytes and NK cells. The results of this work indicates that adipose stem cell population is heterogeneous in cytokine production profile, and that isolation, characterization and selection of the appropriate cell clone is a more exact method for the possible treatment of different patients or pathologies.
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INTRODUCTION
Mesenchymal stem cells (MSCs) are a population of stem cells that can be isolated from a variety of tissues, including bone marrow [1] , umbilical cord [2] , foetal tissues [3] , amniotic liquid [4] , synovial membrane [5] , dental pulp [6] and adipose tissue [7] . Although MSCs are found in very small quantities in vivo, they can be easily expanded in vitro and represent an attractive therapeutic tool for regenerative medicine. In fact, MSCs are multipotent and, as such, can give rise to a variety of mesodermal phenotypes, including osteogenic, adipogenic, chondrogenic, muscle, or stromal cells [8] [9] [10] [11] [12] [13] [14] [15] . In addition, MSCs possess unique immunomodulatory properties, being capable of suppressing T cell responses and modifying dendritic cell differentiation, maturation, and function. Furthermore, these cells are not inherently immunogenic, failing to induce alloreactivity to T cells and freshly isolated natural killer (NK) cells [16] , making them an attractive tool in cell therapy protocols for the treatment of inflammatory-related diseases.
The immunomodulatory properties exhibited by MSCs come in part from the expression of specific protein markers. Unfortunately, as of yet there is no one specific marker that identifies MSCs, thus to identify these cells several surface markers are used. In this respect, one attempt to standardize the phenotypic characterization of MSCs came for the International Society for Cellular Therapy (ISCT). The ISCT proposed that MSC populations must be positive at least for the following surface markers: CD44, CD73, CD90 and CD105 [17] [18] [19] [20] [21] .
Additionally, these cells should lack the expression of haematopoietic antigens such as CD34, CD45 as well as markers for monocytes, macrophages and B cells [21] . CD44 is an adhesion molecule involved in a wide variety of cellular functions including lymphocyte activation, recirculation and homing [22] . CD73 catalyses the conversion of purine 5'-mononucleotides to nucleosides, mainly AMP. Its expression in Treg cells seems to be a part of their regulatory mechanisms [23] . CD90 antigen is known to act to some extent as a CD28-substitute
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activating signal for T-cell receptor signalling [24] . CD105 (endoglin) is part of the TGF-β1 receptor complex. Also, TGF-β signalling [25] is involved in the cytoskeletal organization, affecting cell morphology and migration [26] .
The majority of the studies carried out to phenotypically characterize MSCs have been performed using MSCs cultures without considering the fact that they are a heterogeneous population of cells, as previously shown [27] . In an attempt to better characterize MSCs, in this paper we have analysed for the first time the expression of some of the aforementioned surface antigens in different clones of human MSCs isolated from the adipose tissue (hASCs), while at the same time have identified their Th1/Th2 cytokine profile as well as their ability to inhibit lymphocyte proliferation in culture. Part of the differences observed between clones could be explained by the different pattern of DNA methylation. Finally, potential differences were analysed in the clones that may be applied in a near future in various cell therapy protocols.
MATERIALS AND METHODS
Cells and reagents
This study was conducted according to guidelines written in the Declaration of Helsinki and all procedures involving human subjects/patients were approved by the Ethical Committee of University Miguel Hernandez. Written informed consent was obtained from the two subjects.
Five different hASCs clones isolated from the two healthy subjects were used for all of the experiments (clones 1.10, 1.22, 1.7, 3.10 and 3.5). Clones 1.10, 1.22 and 1.7 were obtained from one of the subjects and will be referred altogether as clones 1.X for further analysis.
Clones obtained from the second subject (3.10 and 3.5) will be referred altogether as clones 3.X. Clones were isolated and cultured as previously described [27] . 
Determination of DNA methylation profile
Microarray-based DNA methylation profiling was performed on all samples with Infinium HumanMethylation27 BeadChip arrays (Illumina, San Diego, CA) as previously described [28] . It accomplishes this high multiplexing by combining bisulfite conversion of genomic DNA and whole genome amplification sample preparation with direct, array based capture and enzymatic scoring of the CpG loci. The assays interrogate the chemically different loci using two site-specific probes, one designed for the methylated locus (M bead type) and The beta value is a quantitative measure of DNA methylation levels of specific cytosineAccepted Article guanine dinucleotide (CpG), and ranges from 0 (completely unmethylated) to 1 (completely methylated). Every beta value in the array platforms is accompanied by a detection p-value.
We based the filtering criteria on these p-values reported by the assays. All probes with detection p-values >0.01 were removed. The clustering heatmaps using methylation data were performed with BeadStudio software (Illumina) and Microsoft Excel tools.
The microarray data from this study have been submitted to the NCBI Gene Expression
Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE44222.
In order to study coincidences between the methylation pattern and the gene expression profile, RT-PCR assays were carried out on specific genes by using the following primers 
hASC-PBMC co-cultures
The studies were performed by co-culturing all of the hASC clones with PBMC isolated from 7 unrelated donors by gradient density centrifugation with Ficoll-Hypaque from GE Healthcare (Chalfont, St Giles, UK). PBMC were washed twice in culture medium (RPMI supplemented with 10% FCS, 1% antibiotic+fungizone, 1% glutamine). hASC clones were first washed twice in PBS, then trypsinised as previously mentioned and resuspended in the same RPMI medium that was also used to resuspend PBMC. Cells were finally plated in triplicates onto flat-bottom 96-well plates in a final volume of 250 l/well, containing hASC/PBMC at the rate of 1:10 (10.000/100.000) or 1:5 (20.000/100.000). Prior to be cultured PBMC were primed with CFSE (Sigma-Aldrich) for 5 min according to Parish [29] .
Proliferation assay
To analyse the effect that hASC clones may have on lymphocyte proliferation, PBMC alone or co-cultured with hASC (n=7) were stimulated with phytohemagglutinin (PHA) (10 g/ml) from Sigma-Aldrich or anti-CD3/anti-CD28 from Becton-Dickinson and further incubated for 5 days at 37ºC and 5% CO 2 . Unstimulated cells for both conditions were used as their respective negative controls.
After the 5-day culture, PBMC were labelled with a combination of anti-CD3, CD4 and CD8 
Statistical analysis
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Statistical analysis was performed with the free R software. Data are presented as the mean the standard error of the mean (SEM) from 3 or more experiments. Analysis of variances (ANOVA) was used to test the type and levels of secreted cytokines for the different clones according to the time of culture, as well as the effect of clones on lymphocyte proliferation.
When the ANOVA F-test found significant differences between levels, post-hoc analyses were conducted using the most restrictive version of Tukey HSD (Honest Significantly Differences) test with the p-value adjusted by the Bonferroni method.
Cytokines were divided into two models since their behaviour throughout time were clearly different. One model was performed to analyse IL-6 and IL-8 cytokines, while the other model contained the rest of cytokines. Each model included clone and cytokine as the fixed factor and time as the random factor. Regarding lymphocyte proliferation, a descriptive analysis was first performed to obtain information concerning the proliferation rate under the different culture conditions. Then, the ANOVA test was used to analyse the data by using two factors (lymphocyte subsets and clones). When no interactions were detected, only one factor was considered to focus on differences between clones. To study the impact of the patient factor on clone behaviour we also analysed the differences between clones 1.X and 3.X.
RESULTS
Membrane phenotype of hASC
Among the clones studied, none expressed CD34 ( Figure 2B Figure   2B ). CD90 was the antigen with the lowest levels of expression, being similar in all the clones analysed ( Figure 2B ). Clone 3.5 presented the highest levels of expression of CD105, while clone 1.7 presented more CD73 and CD44 than the rest of the clones ( Figure 2B ).
Analysis of Th1/Th2 cytokine profile in hASC clones
Basal secretion or in response against different stimuli Similar expression levels of IL-6 and IL-8 were detected in all the clones both under basal culture medium (see Figures 3A and 3B respectively) and after stimulation with LPS or PMA+Ionomycin (no significant differences). Stimulation immediately after tripsinisation of hASCs or 4 days later did not exert any influence on the cytokine levels (data not shown).
With regard to the rest of the cytokines analysed, they were only expressed after stimulation.
Although the cytokines secreted after stimulation of hASCs with LPS or PMA+Ionomycin were almost the same in all of the clones, LPS seemed to be the most powerful stimulus, being 0.2 g/ml the optimal concentration to obtain the highest cytokine levels ( Figure 3C ).
As observed for IL-6 and IL-8, no differences were detected in the type or amount of secreted cytokines according to the moment of stimulation, i.e. after trypsinisation or 4 days later (data not shown). No secretion of IL-10 or IL-12 was detected in any of the hASCs clones.
Kinetics of secreted IL-6 and IL-8
IL-6
The 5 clones produced high amounts of IL-6 ( Figure 3A) . Clones 3.10 and 1.22 presented faster kinetics, reaching high levels of this cytokine in the first 2-4 h of culture. The kinetics of clone 3.5 was slightly slower, producing the most amounts after 24-72 h. Clones 1.7 and
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3.10 reached their higher levels at the end of the crop and continued increasing after 96 h.
Finally, clone 1.22 presented the lowest levels of IL-6 after 96 h of culture.
IL-8
The 5 clones produced mild to moderate levels of IL-8 ( Figure 3B ). Two groups can be distinguished according to their kinetics. The first group (clones 1.10 and 3.5) presented slower kinetics. The second group (clones 1.22, 1.7 and 3.10) presented faster kinetics, reaching levels above 1000 pg/ml in the first 2-4 h of culture. Clone 1.7 secreted the highest amounts of IL-8, while clone 1.22 secreted the lowest. Clones 1.10, 3.5 and 3.10 presented a tendency to increase production after 96 h of culture.
Levels of other secreted cytokines after LPS stimulation
IL-1β
Clones 3.5 and 3.10 produced the highest amounts of this cytokine, followed by clone 1.10
( Figure 3C ). The first two clones peaked after 24 h of culture and clone 1.10 after 48 h (not shown). Clone 1.7 only produced slight amounts of this cytokine and had a faster kinetics, reaching a peak in 4-6 h of culture (not shown).
TNF-
Only clones 1.22 and 1.10 produced this cytokine at very low levels (~10 pg/ml) ( Figure 3C ).
TNF-
All clones produced low levels of TNF- ( Figure 3C ). Clones 1.X exhibited faster kinetics than clones 3.X, reaching a peak within 12 h of culture. Clone 3.10 presented the slowest kinetics (peaks at 48 h) (not shown).
IL-2
All clones produced low to moderate amounts of IL-2 ( Figure 3C ). As in other cases, the kinetics of clones 1.X was the fastest, reaching its peak in the first 4-8 h of culture. Clone 3.5
peaked at 12-24 h and clone 3.10 continued increasing after 72 h (not shown).
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IFN-
Only clone 1.22 produced this cytokine (~25 pg/ml) ( Figure 3C ).
IL-4
All clones produced low to moderate amounts of IL-4 ( Figure 3C ). Clones 1.X presented the fastest kinetics, peaking in the first 4-8 h of culture. Clones 3.X peaked about 12-24 h (not shown).
IL-5
Clones 1.X and 3.10 produced low to moderate amounts of IL-5 ( Figure 3C ). Clones 1.7 and 1.22 presented the fastest kinetics, peaking in the first 4-8 h of culture. Clones 1.10 and 3.10
peaked at 48 and 24 h, respectively (not shown).
Cytokine gene methylation pattern of the different clones
Altogether, the results suggest that there is heterogeneity between the different hASC clones regarding cytokine secretion and kinetics. This heterogeneity may be explained in part by the 
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4 is not expressed in the absence (Figure 4 ) or in the presence of aza-deoxycytidine ( Figure   6 ). These results suggest that DNA methylation might be an instrumental mechanism in controlling the expression of specific cytokines (i.e. IL-10 and TNF-α), but not for others (i.e.
IL-4)
. In any case, these results have to be interpreted with caution because the magnitude of changes that occurred in the methylation pattern of the DNA after incubation of clone 1.10 with 20 μM aza-deoxycytidine is unknown at present.
hASC-PBMC co-cultures and proliferation assay
Proliferation was not observed in unstimulated PBMC cells alone or with hASC. PHA-based stimulation triggered proliferation in the majority of the lymphocyte subsets (data not shown).
Although the PHA-induced proliferation rate was slightly different for each PBMC donor, to homogenize results, lymphocyte proliferation was expressed as part of a unit, according to All the ANOVA comparisons between the proliferation rates observed in hASC clones/PBMC co-cultures and that of lymphocytes alone (PBMC) were highly significant (p < 0.000) (Figures 7 and 8) . The presence of hASCs in the cultures resulted in a significant decrease in proliferation in both total lymphocytes and their subsets (p<0.0001). The rate of inhibition, however, differed among the clones. Depending on their behaviour, two groups can be distinguished ( Figure 7 ). Clones 1.X (grey bars) had a significantly stronger suppressive effect than clones 3.X (white bars) for total lymphocytes (p= 0.0044), CD3 + T lymphocytes (p=0.00504), CD4 + T lymphocytes (p=0.0254), and NK cells (p= 0.0121), but not significant for CD8 + T lymphocytes (p= 0.349).
Also, the 1.X clones were more suppressive than 3.X (Figure 8 ). Figure 8 shows the five clones sorted in descending order according to their inhibitory effect on lymphocyte In this respect, the aim of this approach would be to reduce the use of immunosuppressive drugs and therefore the number of side effects and even to modify the severity of the disease.
Indeed, several studies have shown that MSC are capable of suppressing T-cell and NK responses and to modify B-cell and dendritic cell differentiation, maturation, and function, without being inherently immunogenic [16] . This latter point is extremely important, as it demonstrates that these cells may be isolated from different donors and further expanded in vitro so they can then be used in allogeneic recipients under cell therapy protocols. Numerous
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researchers have already demonstrated the successful recruitment and multi-organ engraftment capability of infused MSC in various animal models and also in human clinical trials [30] [31] [32] [33] . Some authors have shown that when MSC are cultured as single-cell-derived colonies, each individual colony shows variable degree of plasticity in terms of tissue differentiation. This indicates that certain colonies are only capable of differentiating towards a unique lineage while others have a higher differentiation potential [27, 34] . It has to be mentioned that the analysed clones presented certain heterogeneity in their differentiation potential towards the osteogenic and adipogenic lineages [27] . In this respect, clones 1.22 and 1.7 differentiated into both lineages, clone 3.5 displayed only differentiation to the osteogenic lineage and clones 1.10 and 3.10 were not capable to differentiate. The focus of this work was to analyse if this plasticity is also present in the MSCs' immunomodulating properties, and if so, would allow us to select the most adequate clone(s) for each specific case to treat different pathologies. To this end, we sought to analyse the possible differences that may exist between several in vitro expanded hASC clones obtained from two healthy donors, regarding their membrane phenotype expression, cytokine profile and their ability to inhibit lymphocyte proliferation in vitro.
In this context, the conflicting results that may be observed in the literature when using MSCs are possibly due to the different isolation protocols and culture conditions, resulting in a heterogeneous cell population. Furthermore, some works have shown that the source of harvested MSC plays a role in lineage commitment [35, 36] . Even though there is evidence that MSCs are capable of changing their expression pattern of surface markers depending on the culture time [16] , it is important to highlight that all of our clones in this work have been cultured the same amount of time and passages. Regarding membrane phenotype expression, our clones were not significantly different, although a few differences could be detected.
Briefly, clones 3.X seemed to be more homogenous than clones 1.X with respect to their Accepted Article surface antigen expression. This homogeneity, apart from being an indicator of the degree of purity of the clone, could be useful for cell therapy protocols, since the expected results should be in principle more reliable than when using more heterogeneous populations. On the other hand, individual analysis of the clones also showed that there are differences in the expression of several surface antigens. Clones 1.10 and 1.22 expressed lower amounts of antigens than the other three clones, with 1.22 expressing the lowest amounts for all of the antigens. Clones 3.10 and 3.5 expressed more CD105 than the other clones and clone 1.7
expressed the highest amounts of CD73 and CD44. The balance between membrane antigens mainly involved in activating functions such as CD44 or CD90 and markers such as CD73 or CD105 which are more involved in suppressive functions, can determine, together with additional mechanisms, the final immunomodulating properties of the clones. Therefore, from our point of view, when using cell therapy protocols, apart from granting homogeneity as previously mentioned, this antigen balance should also be an additional factor to be considered before choosing a clone for these purposes.
Several studies carried out with whole MSCs demonstrate the ability of these cells to express and/or secrete a broad variety of cytokines that have been shown to be involved to some extent with their immunomodulating properties [37]. Several authors have described two morphologically distinct MSC types according to their in vitro cytokine release: MSC1 which mainly secretes pro-inflammatory cytokines and MSC2 which mainly secretes immunosuppressive cytokines [37] . Therefore, previous analysis of MSC1/MSC2 balance when working with heterogeneous preparations of MSCs is an indirect tool to obtain a more uniform cell culture to be used in possible cell therapies. By measuring the cytokine profiles of expanded MSC clones instead of using heterogeneous populations, we can obtain the same information about the potential immunomodulating activities of each clone and at the same time will allow us further improve the aforementioned desirable uniformity expected for cell Accepted Article therapy protocols. After analysing the cytokine profile of our clones, we have also discovered some interesting differences. In fact, all of our clones were capable of spontaneously releasing high levels of IL-6 and low to moderate levels of IL-8, with 1.7 and 3.X clones producing the highest amounts of these cytokines. In general, these results were coincident with the pattern of cytokine gene expression and the corresponding DNA methylation profile. Regarding kinetics, clones 1.7, 1.22 and 3.10 seemed to present the fastest kinetics and clones 1.10 and 3.5 the slowest. Although IL-6 is a pleiotropic cytokine with both pro-inflammatory and antiinflammatory effects, the former effect usually predominates [38, 39] and has been directly linked to the pathophysiology of diverse autoimmune diseases, in particular rheumatoid arthritis [40] . IL-8 is also involved in pro-inflammatory activities [41] . Kinetics and secretion levels after LPS stimulation from the rest of the analysed cytokines are described in detail in and IL-5 (low to moderate levels), being most abundant in clone 1.22. Altogether, we can conclude that in general terms clones 3.X show a more pro-inflammatory profile while clones 1.10 and 1.22 are more suppressive. Regarding the behaviour of clone 1.7, although belonging to 1.X group it seems however to be more similar to 3.X clones.
Several authors have described an ability of whole heterogeneous MSC populations to inhibit proliferation and activation of different allogeneic immune subsets without being immunogenic themselves [42] . These results offer an insight into the interactions between allogeneic MSCs and immune cells and provide mechanisms that may be involved with the in
vivo MSC-mediated induction of tolerance, which could be used therapeutically for reducing graft rejection or graft-versus-host-disease (GVHD) and for modulating inflammation in autoinflammatory/autoimmune diseases. Nevertheless, these studies often present contradictory results, possibly due to the heterogeneity of MSCs populations used in the different analyses [35] . In an attempt to maximally reduce this heterogeneity, we have analysed here the ability of different ASC clones to inhibit proliferation of several lymphocyte subsets. Similar to what we have described for membrane phenotype and cytokine profile, significant differences between clones 1.X and 3.X have been found. In general terms, 1.X clones are altogether more suppressive than 3.X clones for the different analysed lymphocyte subsets. However, a descriptive individual analysis shows that clone 1.22 was the most suppressive for total and CD3 + lymphocytes, clone 1.7 for CD8 + T lymphocytes and NK cells and clone 1.10 for CD4 + T cells. Clone 3.10 was the least suppressive in all cases, followed by clone 3.5. These results are consistent with the previous data referred in this study. Indeed, clone 1.22, which was the most suppressive, expressed the lowest amounts of surface antigens, secreting low amounts of some of the most powerful pro-inflammatory cytokines and high amounts of anti-inflammatory cytokines. The opposite is true for 3.X clones, which expressed more surface antigens, secreted more pro-inflammatory cytokines and less antiinflammatory cytokines while at the same time were the least suppressive.
ISCIII) (www.cegen.org). Accepted Article Figure 5 
